Guizhou Hao
Guizhou Hao publishes mostly in Molecular Biology, Biomedical Engineering and Pharmaceutical Science, on topics such as Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways and Advanced Drug Delivery Systems.
- World rank
- #4,655,981 of 7,710,434 ranked researchers
- Rank in China
- #707,237 of 978,568
- Works
- 17
- Citations
- 341
- Citations per work
- 20.1
What does Guizhou Hao research?
Guizhou Hao's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Engineering (20%), Pharmacology, Toxicology and Pharmaceutics (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences635.6%
- Everything else635.6%
- Physical Sciences320.0%
- Engineering320.0%
- Health Sciences14.4%
- Medicine14.4%
- Social Sciences14.4%
- Social Sciences14.4%
- 1Molecular Biology27% of their works
- 2Biomedical Engineering16% of their works
- 3Pharmaceutical Science9% of their works
- 4Endocrinology, Diabetes and Metabolism4% of their works
- 5Sociology and Political Science4% of their works
- 6Aerospace Engineering4% of their works
Research topics
Which keywords describe Guizhou Hao's research?
The keywords of their largest research topics: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, Nanoparticles, Air Force, Chitosan, Culture and Extraction.
- Ubiquitin
- Supercritical Water
- Proteasome
- Modernization
- Islam
- Extraction
- Chitosan
- Nanoparticles
- HDAC Inhibitors
- Cancer Therapy
- Histone Deacetylases
- Air Force
- Culture
- Gasification
- Legal Regulation
- Mucosal
- Supercritical Fluids
- Transport Policy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cancer Therapy62 topics
- HDAC Inhibitors41 topic
- Histone Deacetylases41 topic
- Nanoparticles42 topics
- Air Force21 topic
- Chitosan21 topic
- Culture21 topic
- Extraction21 topic
- Gasification21 topic
- Islam21 topic
- Legal Regulation21 topic
- Modernization21 topic
- Mucosal21 topic
- Proteasome21 topic
- Supercritical Fluids21 topic
- Supercritical Water21 topic
- Transport Policy21 topic
- Ubiquitin21 topic
Where does Guizhou Hao work?
Guizhou Hao's main affiliation in the publication record is Luye Pharma (China), China.
How many publications and citations does Guizhou Hao have?
OpenAlex counts 17 works and 341 citations for Guizhou Hao, an h-index of 6, ranking #4,655,981 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Guizhou Hao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.